Patients with overweight/obesity receiving branded semaglutide via a nationwide telehealth platform achieve weight-loss outcomes comparable to those in the STEP 1 trial of GLP-1 receptor agonist.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/remote-care-enables-effective-weight-loss-semaglutide-2026a100001v?src=rss
Author :
Publish date : 2026-01-02 10:14:00
Copyright for syndicated content belongs to the linked Source.